Ask AI
ProCE Banner Activity

Targeting TROP-2 and TIGIT: Experts Discuss How ADCs and Immunotherapeutic Combinations Are Transforming Lung Cancer Treatment

Slideset

Download these slides from a recent webinar to gain a deeper understanding of the mechanisms of action and rationale for targeting TROP-2 and TIGIT in lung cancer based on recent clinical data and novel targeted therapies.

Released: August 28, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.